Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
OptimizeRx price target raised to $40 from $26 at Lake Street » 09:00
01/07/21
01/07
09:00
01/07/21
09:00
OPRX

OptimizeRx

$35.37 /

+0.81 (+2.34%)

Lake Street analyst Eric…

Lake Street analyst Eric Martinuzzi raised the firm's price target on OptimizeRx to $40 from $26 and keeps a Buy rating on the shares after having recently hosted management for a meeting that left him comfortable that the company's "growth story is in its early innings." The analyst, who sees upside to his FY21 revenue estimate of $48M, said he is comfortable with the potential for further stock price appreciation despite a "rich valuation."

ShowHide Related Items >><<
OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

01/07/21 Roth Capital
OptimizeRx price target raised to $70 from $40 at Roth Capital
01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

Recommendations
OptimizeRx price target raised to $70 from $40 at Roth Capital » 08:34
01/07/21
01/07
08:34
01/07/21
08:34
OPRX

OptimizeRx

$35.37 /

+0.81 (+2.34%)

Roth Capital analyst…

Roth Capital analyst Richard Baldry raised the firm's price target on OptimizeRx to $70 from $40 and keeps a Buy rating on the shares. Given its RFP pipeline doubled year-over-year in Q3, the analyst believes OptimizeRx could accelerate organic growth to 100% in 2020. Given Baldry expects both material upside to current forecasts, OptimizeRx is his 2021 Top Pick.

ShowHide Related Items >><<
OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

OPRX OptimizeRx
$35.37 /

+0.81 (+2.34%)

Conference/Events
OptimizeRx participates in a conference call hosted by Lake Street » 13:25
01/06/21
01/06
13:25
01/06/21
13:25
OPRX

OptimizeRx

$35.96 /

+1.4 (+4.05%)

Lake Street holds a…

Lake Street holds a conference call with CEO Febbo and Chief Commercial Officer Silvestro on January 6 at 2 pm.

ShowHide Related Items >><<
OPRX OptimizeRx
$35.96 /

+1.4 (+4.05%)

OPRX OptimizeRx
$35.96 /

+1.4 (+4.05%)

01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$35.96 /

+1.4 (+4.05%)

OPRX OptimizeRx
$35.96 /

+1.4 (+4.05%)

Conference/Events
OptimizeRx participates in a conference call hosted by Lake Street » 04:55
01/06/21
01/06
04:55
01/06/21
04:55
OPRX

OptimizeRx

$34.50 /

+1.02 (+3.05%)

Lake Street holds a…

Lake Street holds a conference call with CEO Febbo and Chief Commercial Officer Silvestro on January 6 at 2 pm.

ShowHide Related Items >><<
OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

Conference/Events
OptimizeRx management to meet virtually with Lake Street » 04:55
01/06/21
01/06
04:55
01/06/21
04:55
OPRX

OptimizeRx

$34.50 /

+1.02 (+3.05%)

Virtual Meeting to be…

Virtual Meeting to be held on January 6 hosted by Lake Street.

ShowHide Related Items >><<
OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

01/04/21 B. Riley Securities
OptimizeRx price target raised to $50 from $34 at B. Riley Securities
11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

OPRX OptimizeRx
$34.50 /

+1.02 (+3.05%)

Recommendations
OptimizeRx price target raised to $50 from $34 at B. Riley Securities » 08:47
01/04/21
01/04
08:47
01/04/21
08:47
OPRX

OptimizeRx

$31.18 /

+0.06 (+0.19%)

B. Riley Securities…

B. Riley Securities analyst Andrew D'Silva raised the firm's price target on OptimizeRx to $50 from $34 and keeps a Buy rating on the shares. The analyst expects the shares to outperform in 2021. During 2020 OptimizeRx showed its ability to act nimbly and introduce innovative, value-add offerings that allowed its life science partners to better manage disruption caused by COVID-19, D'Silva tells investors in a research note. The analyst believes this further imbedded the company within the industry, making its platform more integral for its customers.

ShowHide Related Items >><<
OPRX OptimizeRx
$31.18 /

+0.06 (+0.19%)

OPRX OptimizeRx
$31.18 /

+0.06 (+0.19%)

11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
10/13/20 Roth Capital
Roth sees OptimizeRx pre-announced growth upside supporting bullish breakout
OPRX OptimizeRx
$31.18 /

+0.06 (+0.19%)

OPRX OptimizeRx
$31.18 /

+0.06 (+0.19%)

Conference/Events
OptimizeRx management to meet virtually with Lake Street » 09:09
12/30/20
12/30
09:09
12/30/20
09:09
OPRX

OptimizeRx

$31.02 /

-1.12 (-3.48%)

Virtual Meeting to be…

Virtual Meeting to be held on January 6 hosted by Lake Street.

ShowHide Related Items >><<
OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
10/13/20 Roth Capital
Roth sees OptimizeRx pre-announced growth upside supporting bullish breakout
OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

Conference/Events
OptimizeRx participates in a conference call hosted by Lake Street » 09:01
12/30/20
12/30
09:01
12/30/20
09:01
OPRX

OptimizeRx

$31.02 /

-1.12 (-3.48%)

Lake Street holds a…

Lake Street holds a conference call with CEO Febbo and Chief Commercial Officer Silvestro on January 6 at 2 pm.

ShowHide Related Items >><<
OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
10/13/20 Roth Capital
Roth sees OptimizeRx pre-announced growth upside supporting bullish breakout
OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

OPRX OptimizeRx
$31.02 /

-1.12 (-3.48%)

Over a month ago
Conference/Events
OptimizeRx management to meet virtually with Lake Street » 04:55
12/17/20
12/17
04:55
12/17/20
04:55
OPRX

OptimizeRx

$29.33 /

-0.21 (-0.71%)

Virtual Meeting to be…

Virtual Meeting to be held on December 17 hosted by Lake Street.

ShowHide Related Items >><<
OPRX OptimizeRx
$29.33 /

-0.21 (-0.71%)

OPRX OptimizeRx
$29.33 /

-0.21 (-0.71%)

11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
10/13/20 Roth Capital
Roth sees OptimizeRx pre-announced growth upside supporting bullish breakout
OPRX OptimizeRx
$29.33 /

-0.21 (-0.71%)

OPRX OptimizeRx
$29.33 /

-0.21 (-0.71%)

Conference/Events
OptimizeRx management to meet virtually with Lake Street » 10:00
12/11/20
12/11
10:00
12/11/20
10:00
OPRX

OptimizeRx

$29.30 /

+0.3 (+1.03%)

Virtual Meeting to be…

Virtual Meeting to be held on December 17 hosted by Lake Street.

ShowHide Related Items >><<
OPRX OptimizeRx
$29.30 /

+0.3 (+1.03%)

OPRX OptimizeRx
$29.30 /

+0.3 (+1.03%)

11/11/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
11/10/20 Lake Street
OptimizeRx price target raised to $26 from $21 at Lake Street
11/10/20 B. Riley Securities
OptimizeRx price target raised to $34 from $30 at B. Riley Securities
10/13/20 Roth Capital
Roth sees OptimizeRx pre-announced growth upside supporting bullish breakout
OPRX OptimizeRx
$29.30 /

+0.3 (+1.03%)

OPRX OptimizeRx
$29.30 /

+0.3 (+1.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.